The Kirby-Bauer test is a laboratory method used to determine whether a specific antibiotic can kill or stop the growth of a particular bacterium. Small disks soaked in different antibiotics are placed on a plate covered with bacteria, and after overnight incubation, the lab measures the clear zones around each disk where bacteria couldn’t grow. The size of those zones tells clinicians whether the bacteria are susceptible, intermediate, or resistant to each antibiotic tested.
How the Test Works
The process starts with a sample of bacteria, usually collected from a patient’s infection. The lab grows those bacteria and prepares a standardized suspension containing roughly 100 million bacterial cells per milliliter. Standardizing the concentration matters because too many or too few bacteria would skew the results. This suspension is then spread evenly across the surface of a nutrient-rich agar plate so the bacteria form a uniform lawn of growth.
Small paper disks, each impregnated with a known amount of a specific antibiotic, are placed on the surface of the plate. As the plate sits in an incubator (typically at body temperature for about 16 to 18 hours), the antibiotic in each disk seeps outward into the surrounding agar. The concentration is highest right next to the disk and drops off as the distance increases. Bacteria close to the disk encounter a lethal dose, while bacteria farther away encounter progressively weaker concentrations until the antibiotic is too dilute to have any effect.
The result is a visible clear circle around each disk, called a “zone of inhibition,” where bacteria were unable to grow. The larger the zone, the more effective that antibiotic is against the tested bacterium. No zone at all means the bacteria grew right up to the disk’s edge, a strong sign of resistance.
Reading the Results
After incubation, a lab technician measures the diameter of each zone of inhibition in millimeters using a ruler or caliper. That number is then compared against published breakpoint tables maintained by the Clinical and Laboratory Standards Institute (CLSI), the organization that sets the global standard for antibiotic susceptibility testing. These tables are updated regularly to reflect new resistance patterns and drug approvals.
Based on the measurement, each antibiotic receives one of three classifications:
- Susceptible (S): The zone is large enough to indicate the antibiotic should work at standard doses.
- Intermediate (I): The zone falls in a gray area, meaning the antibiotic might work at higher doses or in body sites where the drug naturally concentrates.
- Resistant (R): The zone is too small (or absent), meaning the bacteria can likely survive treatment with that antibiotic.
The specific millimeter cutoffs vary depending on the antibiotic and the type of bacteria being tested. A 20 mm zone might indicate susceptibility for one drug but resistance for another. This is why the standardized breakpoint tables are essential rather than just eyeballing the plate.
Why It Matters in Medicine
When you have a bacterial infection, your doctor often starts treatment with a broad-spectrum antibiotic before lab results come back. The Kirby-Bauer test helps narrow that choice. If the initial antibiotic turns out to be one the bacteria are resistant to, your doctor can switch to something the test shows will actually work. This is especially important for serious infections like bloodstream infections, pneumonia, or complicated urinary tract infections where using the wrong antibiotic wastes critical time.
The test is also a frontline tool for tracking antibiotic resistance. Hospitals and public health agencies aggregate Kirby-Bauer results from thousands of patients to spot trends, like a local strain of bacteria becoming resistant to a commonly prescribed drug. That surveillance data shapes treatment guidelines and alerts clinicians when they need to change their go-to prescriptions.
What the Test Cannot Tell You
The Kirby-Bauer test gives a qualitative answer: susceptible, intermediate, or resistant. It does not tell clinicians the exact minimum concentration of antibiotic needed to stop bacterial growth. For that, labs use a different method called the minimum inhibitory concentration (MIC) test, which exposes bacteria to a series of progressively lower antibiotic concentrations to find the precise threshold. MIC testing is considered the gold standard for accuracy and is often used for more serious or complex infections.
Studies comparing the two methods have found that disk diffusion results don’t always agree with MIC results. In one analysis of bacteria from urinary tract infections, the disk diffusion test matched MIC results with only about 69% sensitivity for ciprofloxacin (a common UTI antibiotic) and roughly 50% sensitivity for another drug, trimethoprim-sulfamethoxazole. For vancomycin, sensitivity was about 56%, though specificity reached nearly 95%. These numbers mean the disk diffusion test can sometimes call a bacterium susceptible when MIC testing would classify it as resistant, a potentially dangerous discrepancy for patients with drug-resistant organisms.
For routine infections caused by common, predictable bacteria, the Kirby-Bauer test is reliable and practical. But when a lab suspects a highly resistant organism, or when a patient isn’t responding to treatment, MIC testing provides more precise information to guide the next step.
Why This Specific Method Became Standard
Disk diffusion testing existed before William Kirby and A.W. Bauer published their standardized version in the 1960s. The contribution that bears their name was the rigorous standardization of every variable: the thickness of the agar, the concentration of bacteria, the size and antibiotic content of the disks, the incubation temperature and duration, and the breakpoint criteria for interpretation. Before that standardization, different labs running the same test on the same bacteria could get different results depending on their technique.
That standardization is what makes the test reproducible across thousands of labs worldwide. It’s inexpensive, requires no specialized equipment beyond an incubator and measuring tool, and can test multiple antibiotics on a single plate. These practical advantages are why it remains one of the most widely used susceptibility tests in clinical microbiology, even as automated and molecular methods have become available in well-funded laboratories.